ARGX

argenx
D

ARGX

Arincen71/100B

argenx return on equity (ROE)

argenx's return on equity is 17.52%: net income of 1.47B USD over the last twelve months on shareholders' equity of 8.42B USD.

Today
17.52%
Average, 5 years
-2.89%
Low, 5 years
-30.55%
High, 5 years
21.06%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 1.47B ÷ 8.42B = 17.52%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is argenx's return on equity so high?

Net margin
31.1%
profit on each dollar of sales
Asset turnover
0.48×
sales on each dollar of assets
Equity multiplier
1.19×
assets on each dollar of equity
Return on equity
17.6%
FY2025
  • FY202531.1% × 0.48 × 1.19 = 17.6%
  • FY202438.0% × 0.35 × 1.13 = 15.2%
  • FY2023-24.1% × 0.27 × 1.11 = -7.2%
  • FY2022-172.8% × 0.13 × 1.11 = -25.2%
  • FY2021-37.9% × 0.38 × 1.12 = -16.1%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today17.52%1.47B8.42B
FY202531 Dec 202514.39%1.05B7.32B
FY202431 Dec 202415.15%833.04M5.50B
FY202331 Dec 2023-10.37%-425.05M4.10B
FY202231 Dec 2022-25.60%-720.34M2.81B
FY202131 Dec 2021-13.76%-348.75M2.53B
FY202031 Dec 2020-28.53%-477.62M1.67B
FY201931 Dec 2019-16.85%-198.89M1.18B
FY201831 Dec 2018-15.20%-93.63M615.87M
FY201731 Dec 2017-6.65%-27.51M413.82M
FY201631 Dec 2016-33.79%-22.52M66.65M
FY201531 Dec 2015-41.86%-17.06M40.76M
FY201431 Dec 2014-21.45%-13.06M60.90M
FY201331 Dec 2013-28.70%-8.60M29.97M
FY201231 Dec 2012-79.83%-13.29M16.65M
FY201131 Dec 2011-16.91%-4.72M27.90M
FY201031 Dec 2010——10.23M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:Market cap,P/S ratio,Debt to equity,Current ratio,All ratios

Common questions about argenx's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.